A new study led by scientists from the International Agency for Research on Cancer shows that an estimated 741,000 new cases of cancer in 2020 were associated with alcohol consumption globally.
A new prognostic tool helps predict which men with advanced metastatic prostate cancer will respond favorably to a novel targeted therapy.
A cancer survivorship study is focusing on Kentucky cancer survivors with any type of cancer, and comparing the results within the state.
St. Jude Children’s Research Hospital scientists have created a registry, Molecular Analysis of Childhood MELanocytic Tumors (MACMEL), to better understand pediatric melanoma.
Findings from the health outcomes group at Fred Hutchinson Cancer Research Center show that more Medicaid patients with cancer died at home without hospice care during the COVID-19 pandemic.
A study led by researchers at NYU Langone Health and Perlmutter Cancer Center shows that Black men most likely to benefit from advanced prostate cancer therapies are 11% less likely to get them than non-Black men.
Researchers at City of Hope have identified how cancer cells in patients with early-stage breast cancer change and become resistant to hormone or combination therapies, according to a new study published in Nature Cancer.
The ABAT enzyme helps medulloblastoma cells feed, according to a study led by USC Brain Tumor Center and Norris Comprehensive Cancer Center.
A study by Dana-Farber Cancer Institute researchers has given scientists their first look at the genomic landscape of tumors that have grown resistant to drugs targeting the abnormal KRASG12C protein.
In children with rhabdomyosarcoma, a rare cancer that affects the muscles and other soft tissues, the presence of mutations in several genes, including TP53, MYOD1, and CDKN2A, appears to be associated with a more aggressive form of the disease and a poorer chance of survival.